SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 156 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $3,688,000 | -43.6% | 27,900 | -68.4% | 0.02% | -42.9% |
Q1 2018 | $6,535,000 | +343.4% | 88,200 | +267.5% | 0.03% | +154.5% |
Q3 2016 | $1,474,000 | +263.1% | 24,000 | +15.4% | 0.01% | +266.7% |
Q1 2016 | $406,000 | -25.6% | 20,800 | +22.4% | 0.00% | 0.0% |
Q3 2015 | $546,000 | +45.6% | 17,000 | -34.4% | 0.00% | 0.0% |
Q4 2014 | $375,000 | -61.8% | 25,900 | +24.5% | 0.00% | +200.0% |
Q3 2013 | $982,000 | – | 20,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |